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Abstract: 
A quantitative structure activity relationship study was performed on different groups of anti-tuberculosis drug compound for 
establishing quantitative relationship between biological activity and their physicochemical /structural properties. In recent years, 
a large number of herbal drugs are promoted in treatment of tuberculosis especially due to the emergence of MDR (multi drug 
resistance) and XDR (extensive drug resistance) tuberculosis. Multidrug-resistant TB (MDR-TB) is resistant to front-line drugs 
(isoniazid and rifampicin, the most powerful anti-TB drugs) and extensively drug-resistant TB (XDR-TB) is resistant to front-line 
and second-line drugs. The possibility of drug resistance TB increases when patient does not take prescribed drugs for defined time 
period. Natural products (secondary metabolites)  isolated from the variety of sources including terrestrial and marine plants and 
animals, and microorganisms, have been recognized as having antituberculosis action and have recently been tested preclinically 
for their growth inhibitory activity towards Mycobacterium tuberculosis or related organisms. A quantitative structure activity 
relationship (QSAR) studies were performed to explore the antituberculosis compound from the derivatives of natural products . 
Theoretical results are in accord with the in vitro experimental data with reported growth inhibitory activity towards Mycobacterium 
tuberculosis or related organisms. Antitubercular activity was predicted through QSAR model, developed by forward feed multiple 
linear regression method with leave-one-out approach. Relationship correlating measure of QSAR model was 74% (R2 = 0.74) and 
predictive accuracy was 72% (RCV2 = 0.72). QSAR studies indicate that dipole energy and heat of formation correlate well with 
anti-tubercular activity. These results could offer useful references for understanding mechanisms and directing the molecular 
design of new lead compounds with improved anti-tubercular activity. The generated QSAR model revealed the importance of 
structural, thermodynamic and electro topological parameters. The quantitative structure activity relationship provides important 
structural insight in designing of potent antitubercular agent. 
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Background: 
Infectious diseases are influencing the world with their 
morbidity and mortality. Tuberculosis is one among the major 
infectious diseases caused by Mycobacterium tuberculosis [1, 2]. It 
remains the leading cause of mortality due to a bacterial 
pathogen. WHO estimated that there were 8.8 million new cases 
of tuberculosis in 2020. About one-third of the world 
population is infected with M. tuberculosis, 10% of which will 
develop the disease at some point in their lives [3]. Four 
prescribed drugs named as Isoniazid (INH), Rifampin, 
Pyrazinamide, and Ethambutol, are currently used for the 
treatment of active TB for a period of at least 6 months. Due to 
long time period, patients generally failed to complete the 
therapy which leads to the emergence of multidrug resistant TB 
(MDRTB) and extensively drug resistant TB (XDRTB). The 
susceptibility of active TB increases rapidly because of human BIOINFORMATION  open access 
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immunodeficiency virus (HIV) infections, which exacerbated 
the situation. World Health Organization (WHO) has declared 
TB a global public health emergency [4].  Therefore, the 
development of new drugs with activity against multi drug-
resistant (MDR) TB, extensively drug-resistant (XDR) TB, and 
latent TB is a priority task. New drug agents that will shorten 
the duration of current chemotherapy are also needed. Due to 
these factors however, tuberculosis still remains a leading cause 
of death world-wide. Natural products, or their direct 
derivatives, play crucial roles in the modern day chemotherapy 
of tuberculosis [5]. There is currently a re-emerging interest in 
natural products as being able to provide novel structures for 
the drug discovery effort and being particularly effective as 
antibacterial lead [6-8]. In the present study we cover the 
literature published on natural products or their direct 
derivatives that exhibit growth inhibitory activity towards 
mycobacteria, and in particular the causative pathogen of 
tuberculosis,  Mycobacterium tuberculosis. Current natural 
product and related derivative antimycobacterial agents exhibit 
wide-ranging in vitro potency towards M. tuberculosis, with 
minimum inhibitory concentrations (MIC) from 0.2 µg/ml 
(rifampicin) through 10 µg/ml (cycloserine) [9]. The main 
objective of the present study was the search for novel natural 
compounds that would show a promise to become useful 
antimycobacterial agent. A series of compounds of Phenolics 
and quinines, Peptides, Alkaloids, Terpenes: Monoterpenes, 
Diterpenes, Sesquiterpenes, Triterpenes, Steroids and their 
synthetic, semisynthetic derivatives were selected as novel 
antimycobacterial agents for 2D-QSAR studies. In the present 
study, we screen out potential anti-tubercular activity through 
quantitative structure activity relationship (QSAR) for which a 
multiple linear QSAR regression model was developed which 
successfully establishes the anti-tubercular activity of different 
compounds in accord with the in vitro experimental data. The 
2D-QSAR model provides the activity dependent structural 
descriptors and predicts the effective dose of other derivatives, 
and suggests their possible toxicity range. The relationship 
correlating measure of QSAR model was 74% (R2 =0.74) and 
predictive accuracy was 72% (RCV2 = 0.72). Using Lipinsky’s 
‘Rule of Five’ Druggability of studied compounds was 
evaluated and in silico A D M E  a n a l y s i s  w a s  d o n e  t h r o u g h  
bioavailability filters. QSAR studies indicate that dipole energy 
and heat of formation correlate well with anti-tubercular 
activity. These results could offer useful references for 
understanding mechanisms and directing the molecular design 
of new lead compounds with improved antitubercular activity. 
 
Methodology: 
The natural and synthetic drug compounds exhibiting the 
potent antimycobacterial Activity was taken from the reported 
work [14-29].The literature values and general structure of the 
molecule are given in (Table 1, see Supplementary material) 
The activity data given as  MIC values. The biological activity 
value [MIC (µg/ml)] reported in literature are converted to -log 
scale and subsequently used as the dependent variable for the 
QSAR analysis. The -log values of MIC along with the structure 
of the 24 compounds in the series is presented in (Table 2, see 
Supplementary material), the chemical structures of known 
drugs were retrieved through the PubChem compound 
database at NCBI (http://www.pubchem.ncbi.nlm.nih.gov), 
while others are drawn in chem-axon /marwin sketch software. 
All the computational studies were performed using the 
Scigress Explorer v7.7.0.47. The optimization of the cleaned 
molecules was done through MO-G computational application 
that computes and minimizes an energy related to the heat of 
formation. The MO-G computational application solves the 
Schrodinger equation for the best molecular orbital and 
geometry of the ligand molecules. The augmented Molecular 
Mechanics (MM2/MM3) parameter was used for optimizing 
the molecules up to its lowest stable energy state. This energy 
minimization is done until the energy change is less than 0.001 
kcal/mol or the molecules are updated almost 300 times. Then 
optimized molecules were selected for calculation of the 
physiochemical descriptors by inserting biological activity as a 
dependable variable. Various 2D descriptors were calculated 
for optimized structures of the molecules using QSAR module 
of Scigress Explorer v7.7.0.47. A large number of descriptors 
were generated like structural, topological, electro topological 
and thermodynamic descriptor. The descriptor pool was 
reduced by removing invariable column in Scigress Explorer. 
The remaining physicochemical descriptors were taken into 
account for the reported analysis. Manual data selection 
method was used for data selection and variable selection. 
Forward feed multiple linear regression mathematical 
expression was then used to predict the biological response of 
other derivatives. QSAR analysis is a mathematical procedure 
by which the chemical structures of molecules is quantitatively 
correlated with a well defined parameter, such as biological 
activity or chemical reactivity. For example, biological activity 
can be expressed quantitatively as in the concentration of a 
substance required to give a certain biological response. 
Additionally, when physicochemical properties or structures 
are expressed by numbers, one can form a mathematical 
relationship, or quantitative structure-activity relationship, 
between the two. The mathematical expression can then be used 
to predict the biological response of other chemical structures. 
QSAR’s most general mathematical form is;  
Activity = f (physiochemical properties and/or structural 
properties) 
 
A QSAR model attempts to find consistent relationships 
between the variations in the values of molecular properties 
and the biological activity for a series of compounds which can 
then be used to evaluate properties of new chemical entities [10, 
11] Some of the important chemical descriptors used in multiple 
linear regression analysis are: atom count (all atoms), atom 
count (carbon), atom count (hydrogen), atom count (oxygen), 
bond count (all bonds), conformation minimum energy 
(kcal/mole), connectivity index (order 0, standard), connectivity 
index (order 1, standard), connectivity index (order 2, 
standard), dipole moment (debye), dipole vector X (debye), 
dipole vector Y (debye), dipole vector Z (debye), electron 
affinity (eV), dielectric energy (kcal/mole), steric energy 
(kcal/mole), total energy (Hartree), group count (amine), group 
count (carboxyl), group count (ether), group count (hydroxyl), 
group count (methyl), heat of formation (kcal/mole), HOMO 
energy (eV), ionization potential (eV), lambda max UV-visible 
(nm), lambda max far-UV-visible (nm), LogP, LUMO energy 
(eV), molar refractivity, molecular weight, polarizability, ring 
count (all rings), size of smallest ring, size of largest ring, and 
solvent accessibility surface area (Å2). Lipinski’s rule of five 
pharmacokinetics filter was used as a drug likeness test [10]. 
Briefly, this rule is based on the observation that most orally 
administered drugs have a molecular weight (MW) of 500 or BIOINFORMATION  open access 
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less, a logP no higher than 5, five or fewer hydrogen bond 
donor sites, and 10 or fewer hydrogen bond acceptor sites (N 
and O atoms). In addition, the bioavailability of all derivatives 
or test compounds was assessed through topological polar 
surface area analysis. Molinspiration offers free on-line 
cheminformatics services 
(http://www.molinspiration.com/cgi-bin/properties). The 
structures of the molecule were sketched in Molinspiration, and 
the physicochemical properties such as logP, polar surface area, 
number of hydrogen bond donors and acceptors and bioactivity 
scores such as GPCR ligands, kinase inhibitors, ion channel 
modulators etc. were predicted [12]. 
 
 
Figure 1: Fitness plot between experimental and predicted 
activity (log MIC) of training and test set.  
 
Results and Discussion: 
Quantitative structure-activity relationship (QSAR) modeling: 
Structure activity relationship has been denoted by QSAR 
model showing significant activity-descriptors relationship 
accuracy of 74% (R2 = 0.74) and activity prediction accuracy of 
72% (RCV2 = 0.72). Initially a total of 79 drugs were used for 
QSAR modeling against 42 chemical descriptors. Only two 
descriptors were found to be significant and seem to be 
responsible for in vitro anti- tubercular activity (Table 4, see 
Supplementary material). A forward feed multiple linear 
regression QSAR model was developed using leave-one-out 
approach for the prediction of biological activity of anti 
tuberculosis drug molecules. We looked for a simpler descriptor 
for the prediction of biological in vitro activity for studied class 
of compounds. QSAR studies indicate that dipole energy and 
heat of formation correlate well with biological activity (Table 
4, see Supplementary material). The QSAR mathematical 
model equation derived through multiple linear regression 
method is given below, showing relationship between in vitro 
experimental activity (MIC) and dependent two chemical 
descriptors: The best 2DQSAR and the statistics obtained are 
listed below: 
 
Predicted log MIC) (µg/ml) = +2.4116*Dielectric Energy 
(kcal/mole)-0.00395099*Heat  of Formation (kcal/mole) 
+1.64401  
 
[RCV2 = 0.72 (72%) and R2 = 0.74 (74%)] 
 
Eighteen drug molecules with reported anti-mycobacterial 
activity were included in the training data set for comparison 
and six molecules used as test set for evaluation of prediction 
accuracy of QSAR model. Results showed that predicted 
activity of Oleanolic Acid and Betulin were comparable with 
experimental activity. A plot between experimental activity and 
predicted activity for both training and test set, is shown as 
fitness plot (Figure 1). Results indicate that Betulin molecule 
had higher anti –tubercular activity than Oleanolic Acid. 
Compliance   of studied compounds also verified by Lipinski’s 
rule-of-five for drug likeness (Table 3, see Supplementary 
material). Results indicate that compounds follow most of the 
ADME properties, thus leading to a good drug candidate for 
antimycobacterial and antitubercular activity. This helped in 
establishing the pharmacological activity of natural compounds 
for their use as potential drugs. Moreover, when we calculated 
the topological polar surface area (TPSA) as a chemical 
descriptor for passive molecular transport through membranes, 
results showed lower TPSA of natural compounds than 
standard drugs (Table 3, see Supplementary material). TPSA 
allows for prediction of transport properties of drugs and has 
been linked to drug bioavailability. Generally, it has been seen 
that passively absorbed molecules with a TPSA > 140 Å2 are 
thought to have low oral bioavailability [13]. On the basis of 
bioavailability scores, we concluded that natural compounds 
have marked antimycobacterial activity but higher log P as 
compared to standard drugs.  
 
Model 1 
C=+2.28525*Q-0.00361321*T+1.6501 rCV^2=0.66622 
r^2=0.703016. 
 
Model 2 
C=+2.22983*Q-0.00324021*T+1.66726 rCV^2=0.681594 
r^2=0.72418 
 
Model 3 
 C=+2.40735*Q-0.00423825*T+1.6047 rCV^2=0.700135 
r^2=0.723656 
 
Model 4 
C=+2.4116*Q-0.00395099*T+1.64401 rCV^2=0.72135 
r^2=0.744826 
 
Conclusion: 
Twenty four natural and synthetic drug compounds are 
evaluated for antimycobacterial activity by 2D QSAR studies 
with oleanolic acid and betulin exhibiting good activity. The 2D 
technique indicates the importance of dielectric energy and heat 
of formation of the compounds on activity. ADME and Tox 
Predictions indicate that these compounds do not violate the 
Lipinski’s rule of five. In this sequence, dielectric energy, heats 
of formation physico-chemical parameter are common in all 
four models. These parameter show positive contribution in all 
four models. Therefore it is considered as desirable properties 
of MTB inhibitors. Comparison of different statistical 
parameters and validation parameters  for models 1-4 suggests 
model 4 for further consideration. It has good correlation 
between biological activity and parameters as RCV2 = 0.72 
(72%) and R2 = 0.74 (74%) variance in inhibitory activity. The 
low standard error demonstrates accuracy of the model. 
Descriptors used in the Significant QSAR Model-4 with value is 
given in Table 4. QSAR model with reliable predictive power 
for MTB inhibitory activity has been successfully demonstrated. 
The good correlation between experimental and predicted BIOINFORMATION  open access 
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biological activity for compounds in the test set further 
highlights the reliability of the constructed QSAR model. The 
finding of the study will be helpful in the design of the potent 
MTB inhibitors which are useful for anti-tubercular activity. 
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Supplementary material: 
 
Table 1: Biological activity data and calculated –Log value for compounds 
Chemical Sample and 
PubChem ID 
MIC MIC=log(B) 
CID_2794_Clofazimine 0.31  -0.509 
CID_3893_Lauric 10  1 
CID_5922_Isonicotinic 12  1.079 
CID_6098_Cloxacillin 0.31  -0.509 
CID_8655_Syringaldehyde 25 1.398 
CID_10494_Oleanolic 28.7  1.458 
CID_64945_Ursolic 41.9  1.622 
CID_64971_Betulinic 62.1  1.793 
CID_64972_Calanolide 12  1.079 
CID_72326_Betulin 30  1.477 
CID_72943_Heteronemin 6.25  0.796 
CID_73214_Eperozolid 0.25  -0.602 
CID_149096_Ofloxacin 0.5  -0.301 
CID_152946_Moxifloxacin 0.375  -0.426 
CID_441401_Linezolid 0.5  -0.301 
CID_445629_Thiolactomycin 5  0.699 
CID_463811_Litosterol 3.13  0.496 
CID_465951_Oxazolidininone 1  0 
CID_477494_Nephalsterol 12.5  1.097 
CID_638072_Squalene 100  2 
CID_3008606_Lecheronol B  128  2.107 
CID_5280450_Linoleic 10  1 
CID_6480075_Bornyl 25  1.398 
CID_10018804_Lecheronol A  4  0.602 
 
Table 2:  Molecule structures and references considered for 2D-QSAR study along with experimental & calculated activities   
S. 
No. 
PubChem Compound ID and 
Name  
Exp MIC 
µg/ml 
Structure Exp   
log MIC 
Pred 
log 
MIC 
References 
1 CID_2794_Clofazimine  0.31 
 
-0.509  -0.155 
 
14 
2 CID_3893_Lauric  Acid  10 
 
1  1.526 
 
15 
3* CID_5922_Isonicotinic  Acid 
 
 
12 
 
1.079 
 
0.89 
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4 CID_6098_Cloxacillin 
 
0.31 
 
 
-0.509 
 
-0.292 
 
17 
5 CID_8655_Syringaldehyde  25 
 
1.398 0.785 
 
15 
6 CID_10494_Oleanolic  Acid  28.7 
 
1.458  1.433 
 
18 
7* CID_64945_Ursolic  Acid  41.9 
 
1.622  1.429 
 
19 
8 CID_64971_Betulinic  Acid  62.1 
 
1.793  1.375 
 
20 
9 CID_64972_Calanolide  A  12 
 
1.079  1.11 
 
21 
10 CID_72326_Betulin  30 
 
1.477  1.487 
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11 CID_72943_Heteronemin  6.25 
 
0.796  1.116 
 
22 
12 CID_73214_Eperozolid  0.25 
 
-0.602  -0.87 
 
23 
* 
13 
CID_149096_Ofloxacin  0.5 
 
-0.301  -0.241 
 
24 
* 
14 
CID_152946_Moxifloxacin  0.375 
 
-0.426  -0.062 
 
25 
15 CID_441401_Linezolid  0.5 
 
-0.301  -0.164 
 
23 
* 
16 
CID_445629_Thiolactomycin  5 
 
0.699  0.887 
 
26 
17 CID_463811_Litosterol  3.13 
 
0.496  1.455 
 
18 
18 CID_465951_Oxazolidininone  1 
 
0  -0.235 
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*= Test set 
 
Table 3:  Compliance of compounds with computational parameters of drug likeness. Lipinski’s Rule of Five and the number of 
violations (using Molinspiration online tool) 
S 
No. 
PubChem Compound ID and 
Name 
TPSA 
(Å2) 
Molecular 
weight 
[g/mol] 
Log 
P 
H-bond 
donors 
(OH 
group) 
H-bond 
acceptors 
(O atom) 
No. of rule of five 
violations 
1  CID_2794_Clofazimine  40  473.39638   7.1  1 4  1 
2  CID_3893_Lauric Acid  37.3  200.31776  4.2  1 2  0 
3  CID_5922_Isonicotinic Acid  50.2  123.1094  0.4  1 3  0 
4  CID_6098_Cloxacillin  138  435.88132  2.4  2 6  0 
5  CID_8655_Syringaldehyde  55.8  182.1733  0 1  4  0 
6  CID_10494_Oleanolic acid  57.5  456.70032  7.5  2 3  1 
* 
19 
CID_477494_Nephalsterol C  12.5 
 
1.097  1.225 
 
18 
20 CID_638072_Squalene  100 
 
2  1.5 
 
27 
21 CID_3008606_Lecheronol  B  128 
 
2.107  1.018 
 
20 
22 CID_5280450_Linoleic  Acid  10 
 
1 1.354 
 
28 
23 CID_6480075_Bornyl  piperate  25 
 
1.398  0.956 
 
29 
24 CID_10018804_Lecheronol  A  4 
 
0.602  0.925 
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7  CID_64945_Ursolic acid  57.5  456.70032  7.3 2  3  1 
8  CID_64971_Betulinic acid  57.5  456.70032  8.2 2  3  1 
9  CID_64972_Calanolide A  65  370.43884  3.8 1  5  0 
10  CID_72326_Betulin  40.5  442.7168  8.3  2 2  1 
11  CID_72943_Heteronemin  82.1  502.68264  6.1  1 6  2 
12  CID_73214_Eperozolid  102  394.397423  -0.3  2 7  0 
13  CID_149096_Ofloxacin  73.3  361.367503  -0.4  1 8  0 
14  CID_152946_Moxifloxacin  82.1  401.431363  0.6  2 8  0 
15  CID_441401_Linezolid  71.1  337.346103  0.7  1 6  0 
16  CID_445629_Thiolactomycin  62.6  210.29266  3.1 1  2  0 
17  CID_463811_Litosterol  40.5  414.66364  7.4  2 2  1 
18  CID_465951_Oxazolidininone  87.2  353.411703  1.5  1 5  0 
19  CID_477494_Nephalsterol C  66.8  472.69972  6.9  2 4  1 
20  CID_638072_Squalene  0  410.718  11.6  0 0  1 
21  CID_3008606_lecheronol B  57.5  318.4504  3.2  2 3  0 
22  CID_5280450_Linoleic Acid  37.3  280.44548  6.8  1 2  1 
23  CID_6480075_Bornyl piperate  44.8  354.43944  5.0  0 4  0 
24  CID_10018804_Lecheronol A  57.5  318.4504  2.9  2 3  0 
 
Table 4:  Comparison of experimental and predicted in vitro activity data calculated through QSAR modeling based on the two 
most highly correlated chemical descriptors 
PubChem Compound ID 
and Name 
Actual 
activity 
Dielectric Energy 
(kcal/mole) 
Heat of Formation 
(kcal/mole) 
Predicted activity 
CID_2794_Clofazimine  -0.509  -0.493  154.142  -0.155 
CID_3893_Lauric acid  1  -0.34  -177.594  1.526 
CID_5922_Isonicotinic acid  1.079  -0.418  -64.663  0.89 
CID_6098_Cloxacillin  -0.509  -0.917  -69.769  -0.292 
CID_8655_Syringaldehyde  1.398  -0.579  -135.924  0.785 
CID_10494_Oleanolic acid  1.458  -0.426  -206.579  1.433 
CID_64945_Ursolic acid  1.622  -0.425  -205.099  1.429 
CID_64971_Betulinic acid  1.793  -0.438  -199.158  1.375 
CID_64972_Calanolide A  1.079  -0.512  -177.397  1.11 
CID_72326_Betulin  1.477  -0.317  -153.824  1.487 
CID_72943_Heteronemin  0.796  -0.697  -292.066  1.116 
CID_73214_Eperozolid  -0.602  -0.87  -1.396  -215.677 
CID_149096_Ofloxacin -0.301  -1.027  -149.473  -0.241 
CID_152946_Moxifloxacin -0.426  -0.92  -129.673  -0.062 
CID_441401_Linezolid  -0.301  -1.031  -171.819  -0.164 
CID_445629_Thiolactomycin  0.699  0.887  -0.384  -42.989 
CID_463811_Litosterol  0.496  -0.346  -163.115  1.455 
CID_465951_Oxazolidininone  0  -0.987  -126.673  -0.235 
CID_477494_Nephalsterol 1.097  -0.574  -244.262  1.225 
CID_638072_Squalene  2  -0.112  -31.924  1.5 
CID_3008606_Lecheronol B  2.107  -0.495  -143.707  1.018 
CID_5280450_Linoleic 1  -0.382  -159.736  1.354 
CID_6480075_Bornyl piperate   1.398  -0.465  -109.48  0.956 
CID_10018804_Lecheronol A  0.602  -0.527  -139.711  0.925 
 